Table 3.
Indicators and weights in GHI.
| Dimension | Sub-dimension | Number | Indicator | Weight |
|---|---|---|---|---|
| A prevalence of GNND and GN | A1 prevalence of GN | A01 | Incidence of oesophageal cancer | 0.028 |
| A02 | Mortality of oesophageal cancer | 0.0208 | ||
| A03 | Incidence of stomach cancer | 0.0401 | ||
| A04 | Mortality of stomach cancer | 0.0271 | ||
| A05 | Incidence of colorectal cancer | 0.0198 | ||
| A06 | Mortality of colorectal cancer | 0.0149 | ||
| A07 | Incidence of liver cancer | 0.0341 | ||
| A08 | Mortality of liver cancer | 0.0097 | ||
| A09 | Incidence of pancreatic cancer | 0.0083 | ||
| A10 | Mortality of pancreatic cancer | 0.0341 | ||
| A2 prevalence of GNND | A11 | Prevalence of liver cirrhosis | 0.0166 | |
| A12 | Mortality of liver cirrhosis | 0.0088 | ||
| A13 | Prevalence of peptic ulcer | 0.0063 | ||
| A14 | Mortality of peptic ulcer | 0.0018 | ||
| A15 | Prevalence of gastro-oesophageal reflux disease | 0.0065 | ||
| A16 | Prevalence of IBD | 0.0122 | ||
| A17 | Mortality of IBD | 0.0046 | ||
| A18 | Prevalence of pancreatitis | 0.0216 | ||
| A19 | Mortality of pancreatitis | 0.0093 | ||
| B exposure to risk factors | B1 environmental factors | B01 | Quality of drinking water | 0.0394 |
| B2 biological factors | B02 | HP infection rate | 0.0122 | |
| B03 | Incidence of hepatitis B and C | 0.0184 | ||
| B3 lifestyle | B04 | Current smoking rate | 0.0159 | |
| B05 | Per capita salt intake | 0.008 | ||
| B06 | Harmful drinking rate | 0.005 | ||
| B07 | Excessive intake of red meat | 0.0056 | ||
| B08 | Insufficient intake rate of vegetable and fruit | 0.0053 | ||
| B09 | Obesity rate | 0.0104 | ||
| B10 | Prevalence of dyslipidemia | 0.0062 | ||
| C prevention and control of risk factors | C1 prevention and control of high-risk factors | C01 | Successful smoking cessation rate | 0.1253 |
| C2 endoscopic screening | C02 | The examination rate of diagnostic oesophagogastroduodenoscopy | 0.0661 | |
| C03 | The examination rate of diagnostic colonoscopy | 0.0232 | ||
| C3 early diagnosis and early treatment of tumours | C04 | Proportion of early cancer in all oesophageal cancer during diagnostic EGD | 0.0139 | |
| C05 | Proportion of early cancer in all gastric cancer during diagnostic EGD | 0.018 | ||
| C06 | Proportion of early cancer in all colorectal cancer during diagnostic colonoscopy | 0.0079 | ||
| C07 | Adenoma detection rate of colonoscopy | 0.0062 | ||
| D clinical treatment of GD | D1 therapeutic capacity | D01 | Proportion of hospitals with gastroenterology department | 0.0194 |
| D02 | Number of gastrointestinal endoscopists | 0.019 | ||
| D03 | Proportion of hospitals with gastrointestinal endoscopy centers | 0.0247 | ||
| D04 | Proportion of hospitals with emergency gastroscopic haemostasis capability | 0.0365 | ||
| D05 | Proportion of hospitals providing primary endoscopic techniques | 0.0234 | ||
| D06 | Proportion of hospitals providing advanced endoscopic techniques | 0.0415 | ||
| D07 | Proportion of regional medical centers for IBD | 0.0113 | ||
| D08 | Proportion of HP standardised outpatient demonstration centers | 0.0111 | ||
| D2 treatment outcome | D09 | Complete resection rate of ESD for early cancer | 0.011 | |
| D10 | 5-Year survival rate of GN | 0.0905 |
ESD, endoscopic submucosal dissection; EGD, oesophagogastroduodenoscopy; IBD, inflammatory bowel disease; HP, Helicobacter pylori.